|

Consolidation therapy-Pro-pola regimen Clinical Trials

1 actively recruiting trial

Top Sponsors

  • The First Affiliated Hospital of Soochow University1

Indications

  • Diffuse Large B-Cell Lymphoma1
  • Cancer1

Other1 trial

Pomalidomide, Rituximab and Orelabrutinib Combined With Polatuzumab Vedotin in the Treatment of Newly Diagnosed Elderly Patients With DLBCL
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.